Literature DB >> 30869494

[Leclercia adecarboxylata and Raoultella ornithinolytica catheter-related infection in a child with mitocondrial disease].

María Sánchez-Códez1, Manuel Lubián-Gutiérrez2, José A Blanca-García3, Cristina Pérez Aragón4.   

Abstract

Leclercia adecarboxylata and Raoultella ornithinolytica are emergent Gram-negative bacteria. Infections caused by these microorganisms are exceptional. Improvement of microbiologist techniques in the last years has enabled their detection and more accurate knowledge. We present the case of an 11-year-old boy with mitochondrial disease with a longterm central catheter who suffered from two sepsis caused by L. adecarboxylata and R. ornithinolytica, respectively. In catheter-related infections, sometimes it is possible to provide antimicrobial treatment without removal of catheter with good results, as in our patient. It is important to recognize L. adecarboxylata and R. ornithinolytica like increasingly frequent pathogenic bacteria, mostly in immunocompromised or chronic patients. Sociedad Argentina de Investigación Odontológica.

Entities:  

Keywords:  Catheter-related infections; Enterobacteriaceae; Mitochondrial diseases; Pediatrics; Sepsis

Mesh:

Substances:

Year:  2019        PMID: 30869494     DOI: 10.5546/aap.2019.e147

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  2 in total

1.  Leclercia adecarboxylata invasive infection in a patient with Hirschsprung disease: A case report.

Authors:  Adnane Aarab; Abderrazak Saddari; Benhamza Noussaiba; Anass Ayyad; Sahar Messaoudi; Rim Amrani; Elmostapha Benaissa; Yassine Ben Lahlou; Adil Maleb; Mostafa Elouennass
Journal:  Ann Med Surg (Lond)       Date:  2021-10-09

2.  Analysis of Anti-Infective Treatment of 9 Neonates with Raoultella ornithinolytica Sepsis.

Authors:  Jing Li; Yan Zhuang; Dingliang Xiao; Haixia Zhang; Fangmei Luo; Jinhua He
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-21       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.